NH House Testimony

SB465

Senate · 2026 sessionRepublicanKilled in House

Classifying xylazine as controlled drug

AI

Classifies xylazine as a schedule III controlled drug.

classifying xylazine as a schedule III controlled drug.

Crimes, Crim.Proc. & Corr.Public and Mental Health

Status

Killed in the House — Inexpedient to Legislate · April 23, 2026
  1. Introduced
  2. Senate
  3. House
  4. Governor
  5. Law

Division of testimony

8 submissions
Support 6Oppose 2Neutral 0
Angela BoyleSupportConcord, NHfor NH Psychiatric SocietyMar 31, 2026

Position recorded without written comment.

Pamela HardersOpposeManchester, NHfor MyselfMar 31, 2026

Position recorded without written comment.

Valerie DanielsonSupportBedford, NHfor MyselfMar 31, 2026

Position recorded without written comment.

Susan HomolaSupportHollis, NHfor SAM NHMar 31, 2026

Position recorded without written comment.

Emily ZajanoSupportExeter, NHfor MyselfMar 31, 2026

Position recorded without written comment.

erick sawtelleSupportLee, NHfor MyselfMar 31, 2026

Position recorded without written comment.

Curtis HowlandOpposeManchester, NHfor MyselfMar 31, 2026

Position recorded without written comment.

Senator David RochefortSupportSenate District 1, NHfor Senate District 1Mar 31, 2026

Position recorded without written comment.